{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:49:31Z","timestamp":1772675371666,"version":"3.50.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Neurosteroids have emerged as promising candidates for treatment for neuroinflammatory diseases, distinct from their classical GABAergic effects. We previously demonstrated that 3\u03b1,5\u03b1-THP inhibits binding of the Lipid A moiety of lipopolysaccharide to the Toll-like receptor 4 (TLR4): Myeloid Differentiation factor 2 (MD-2) protein complex with nanomolar affinity, suggesting that this mechanism may underlie its ability to inhibit TLR4 signal activation in macrophages and brain. This study investigates the structure activity relationships (SAR) for this action of pregnane neurosteroids, focusing on their interactions with MD-2. Through a combination of molecular docking, surface plasmon resonance, and molecular dynamics simulations, we evaluated how modifications to the A, C, and D rings of neurosteroids influence their interactions with MD-2, including binding affinity, orientation, and conformation. The data reveal that hydrophobic interactions, particularly involving PHE151, may be key to neurosteroid binding to MD-2, and that D ring modification may alter the competitive inhibition of Lipid A binding and subsequent TLR4 activation by pregnane steroids. Furthermore, the prototypical neurosteroids 3\u03b1,5\u03b1-THP and progesterone demonstrated deeper MD-2 pocket binding and greater MD-2 stabilization, while SGE 516 induced MD-2 flexibility and weaker competitive inhibition compared to 3\u03b1,5\u03b1-THP. These insights establish a unique structural and mechanistic basis for the immunomodulatory activity of these neurosteroids and offer a novel conceptual framework for future rational design of therapeutics targeting TLR4-mediated neuroinflammation.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1632891","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:12:28Z","timestamp":1756959148000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Structural modifications to pregnane neurosteroids alter inhibition of LPS\/Lipid A binding at the MD-2 activation site within the TLR4 signaling complex"],"prefix":"10.3389","volume":"16","author":[{"given":"Alejandro G.","family":"Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkat R.","family":"Chirasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Balan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Leslie","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2011.00044","article-title":"Neurosteroids and GABA-A receptor function","volume":"2","author":"Wang","year":"2011","journal-title":"Front Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/brainsci8040072","article-title":"The GABA(A) receptor \u03b12 subunit activates a neuronal TLR4 signal in the ventral tegmental area that regulates alcohol and nicotine abuse","volume":"8","author":"Balan","year":"2018","journal-title":"Brain Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41386-023-01721-1","article-title":"Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions","volume":"49","author":"Patterson","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2016.04.003","article-title":"Clinical potential of neurosteroids for CNS disorders","volume":"37","author":"Reddy","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"111168","DOI":"10.1016\/j.pnpbp.2024.111168","article-title":"Allopregnanolone and intrusive memories: A potential therapeutic target for PTSD treatment","volume":"136","author":"Amir Hamzah","year":"2025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108299","DOI":"10.1016\/j.pharmthera.2022.108299","article-title":"Neurosteroids (allopregnanolone) and alcohol use disorder: From mechanisms to potential pharmacotherapy","volume":"240","author":"Gatta","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B7","first-page":"65","article-title":"Progesterone administration modulates TLRs\/NF-kappaB signaling pathway in rat brain after cortical contusion","volume":"38","author":"Chen","year":"2008","journal-title":"Ann Clin Lab Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"104473","DOI":"10.1016\/j.ebiom.2023.104473","article-title":"Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathways","volume":"89","author":"Balan","year":"2023","journal-title":"EBioMedicine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41398-021-01266-1","article-title":"Neurosteroid allopregnanolone (3\u03b1,5\u03b1-THP) inhibits inflammatory signals induced by activated MyD88-dependent toll-like receptors","volume":"11","author":"Balan","year":"2021","journal-title":"Transl Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/s41598-018-37409-6","article-title":"Endogenous neurosteroid (3\u03b1,5\u03b1)3-hydroxypregnan-20-one inhibits toll-like-4 receptor activation and pro-inflammatory signaling in macrophages and brain","volume":"9","author":"Balan","year":"2019","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940095","article-title":"Inhibition of human macrophage activation via pregnane neurosteroid interactions with toll-like receptors: Sex differences and structural requirements","volume":"13","author":"Balan","year":"2022","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2009.07.003","article-title":"Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression","volume":"125","author":"Su","year":"2009","journal-title":"Immunol Lett"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-013-1188-6","article-title":"Role of progesterone in TLR4-MyD88-dependent signaling pathway in pre-eclampsia","volume":"33","author":"Zhu","year":"2013","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3390\/biom14111441","article-title":"Novel inhibitory actions of neuroactive steroid [3\u03b1,5\u03b1]-3-hydroxypregnan-20-one on toll-like receptor 4-dependent neuroimmune signaling","volume":"14","author":"Lopez","year":"2024","journal-title":"Biomolecules"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4\u2013MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp Mol Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ni809","article-title":"Essential role of MD-2 in LPS responsiveness and TLR4 distribution","volume":"3","author":"Nagai","year":"2002","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-020-02066-2","article-title":"Potential roles of myeloid differentiation factor 2 on neuroinflammation and its possible interventions","volume":"57","author":"Oo","year":"2020","journal-title":"Mol Neurobiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.08.203","article-title":"Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signaling","volume":"323","author":"Ohta","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903543","article-title":"Identification of a novel human MD-2 splice variant that negatively regulates Lipopolysaccharide-induced TLR4 signaling","volume":"184","author":"Gray","year":"2010","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J Cheminformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J Comput Chem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J Chem Phys"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1021\/ct700200b","article-title":"P-LINCS:\u2009 A parallel linear constraint solver for molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J Chem Theory Comput"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: An N\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J Chem Inf Modeling"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502074","article-title":"Molecular basis of the functional differences between soluble human versus murine MD-2: role of val135 in transfer of lipopolysaccharide from CD14 to MD-2","volume":"196","author":"Va\u0161l","year":"2016","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.3390\/molecules26185698","article-title":"Molecular basis of artemisinin derivatives inhibition of myeloid differentiation protein 2 by combined in silico and experimental study","volume":"26","author":"Qiao","year":"2021","journal-title":"Molecules"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1525639113","article-title":"TLR4\/MD-2 activation by a synthetic agonist with no similarity to LPS","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00489","article-title":"Computational insight into the structural organization of full-length toll-like receptor 4 dimer in a model phospholipid bilayer","volume":"9","author":"Patra","year":"2018","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1039\/C5MB00085H","article-title":"Insights into the binding mode of curcumin to MD-2: studies from molecular docking, molecular dynamics simulations and experimental assessments","volume":"11","author":"Wang","year":"2015","journal-title":"Mol Biosyst"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1039\/D1RA07377J","article-title":"Docking studies and molecular dynamics simulation of triazole benzene sulfonamide derivatives with human carbonic anhydrase IX inhibition activity","volume":"11","author":"P","year":"2021","journal-title":"RSC Adv"},{"key":"B36","doi-asserted-by":"publisher","first-page":"100111","DOI":"10.1016\/j.xinn.2021.100111","article-title":"Nicotine and its metabolite cotinine target MD2 and inhibit TLR4 signaling","volume":"2","author":"Li","year":"2021","journal-title":"Innovation (Camb)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.873054","article-title":"ACT001 inhibits TLR4 signaling by targeting co-receptor MD2 and attenuates neuropathic pain","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220785","article-title":"Zuranolone for the treatment of postpartum depression","volume":"180","author":"Deligiannidis","year":"2023","journal-title":"Am J Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01724-0","article-title":"Ganaxolone: first approval","volume":"82","author":"Lamb","year":"2022","journal-title":"Drugs"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M807822200","article-title":"Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control *","volume":"284","author":"Wan","year":"2009","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1632891\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:12:33Z","timestamp":1756959153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1632891\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2025.1632891"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1632891","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"article-number":"1632891"}}